Welcome, visitor! [ Register | Login rss Google+ facebook twitter LinkedIn Pinterest FeedBurner

Anaeropharma Science, Inc. – A biopharmaceutical company to develop anti-cancer drug using Bifidobacterium


Anaeropharma Science, Inc. – A biopharmaceutical company to develop anti-cancer drug using Bifidobacterium
 

Anaeropharma Science is a privately held biopharmaceutical company based in Chiyoda-ku, Tokyo, Japan. In 2004, Anaeropharma Science was established to pioneer the development of novel therapeutics to target a hypoxic environment in solid cancers based on its proprietary platform technology, i-DPS(in situ Delivery and Production System), using recombinant Bifidobacterium. The company aims to leverage the recombinant bifidobacterium technology to create a new class of anti-cancer drugs.

The company’s laboratory is located in the campus of Shinshu University in Matsumoto, Nagano Prefecture.

Laboratory
2F, Center for Shinshu Medical Innovation of Regional Technology, Shinshu University
3-1-1, Asahi, Matsumoto, Nagano 390-8621 JAPAN

Overview
Anaeropharma strives for creating innovative therapies for solid cancer and other hypoxic lesions related diseases like ischemia based on our core platform technology, i-DPS. We have established several development programs including APS001F applied for solid cancer under phase I/II clinical trial, anticancer drugs in the area of immuno-oncology and an anti-ischemic drug under preclinical development stage. The company creates value of their platform technology by proceeding with these preclinical and clinical programs based on i-DPS technology.

Ad Reference ID: 9565bad691239fed

No Tags

  

Leave a Reply

You must be logged in to post a comment.

To inquire about this ad listing, complete the form below to send a message to the ad poster.

Group Site

  • Ad 1
  • Ad 2
  • Ad 3
  • Ad 4